Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Step-up dose onabotulinumtoxinA for upper and lower limb spasticity in Japan
jRCT1031230129Completed
- Sponsor
- GSK
- Start
- May 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in Muscle spasm, upper extremity spasticity and lower extremity spasticity (2 cohorts), sponsored by GSK. Started May 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasmupper extremity spasticitylower extremity spasticity
Beyond the preview
Go deeper on jRCT1031230129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031230129.